Market Tracker

05/27 6:02pm ET

Impax Laboratories Inc (NASDAQ:IPXL)

46.11
Delayed Data
As of May 27
 +0.83 / +1.83%
Today’s Change
22.12
Today|||52-Week Range
52.10
+45.55%
Year-to-Date
No recent news for Impax Laboratories Inc.

Today’s Trading

Previous close45.28
Today’s open45.45
Day’s range45.13 - 46.16
Volume502,666
Average volume (3 months)712,238
Market cap$3.2B
Dividend yield--
Data as of 4:00pm ET, 05/27/2015

Growth & Valuation

Earnings growth (last year)-44.90%
Earnings growth (this year)+2.24%
Earnings growth (next 5 years)+26.41%
Revenue growth (last year)+16.53%
P/E ratio72.7
Price/Sales3.62
Price/Book3.63

Competitors

 Today’s
change
Today’s
% change
CLVSClovis Oncology Inc+1.59+1.72%
WXWuXi PharmaTech (Cay...+0.10+0.23%
RAREUltragenyx Pharmaceu...+4.10+4.96%
ANACAnacor Pharmaceutica...+2.42+3.63%
Data as of 4:02pm ET, 05/27/2015

Financials

Next reporting dateAugust 4, 2015
EPS forecast (this quarter)$0.37
Annual revenue (last year)$596.0M
Annual profit (last year)$57.4M
Net profit margin9.62%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
George Frederick Wilkinson
Chief Financial Officer &
Senior Vice President
Bryan M. Reasons
Corporate headquarters
Hayward, California

Forecasts